Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01193764 · ClinicalTrials.gov registry record · NA

Study Assessing the Effect of Chocolate Consumption in Subjects With A History of Acne Vulgaris

A NA study, sponsored by University of Miami.

Terminated
Registry status
NA
Development phase
14
Enrollment target

NCT01193764: Clinical Trial NA study, sponsored by University of Miami.

NCT01193764 is a NA study that was terminated before completion, run by University of Miami. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01193764, a NA study, was terminated before completion, sponsored by University of Miami.

TERMINATED
Registry status
NA
Development phase
14 participants
Enrollment target

Study Summary

The investigators conducted a recent pilot study and found a strong positive correlation between the consumption of 100% chocolate and acne exacerbation. However, this study had limitations including the lack of placebo and the small sample size. Although studies have been conducted assessing chocolate's effect on acne, no study has been done evaluating this effect using chocolate with 100% cocoa content in a double blind placebo controlled fashion. This study will analyze the difference in the number and type of acneiform lesions per subject at the different time points (Day 4 and Day 7) compared to baseline in order to increase the validity of the investigators results. In addition, the investigators will use unsweetened cocoa powder,12 rather than chocolate candy, which contains higher quantities of additive ingredients such as sugar and milk to avoid interference with the results and the possibility to establish or not an association between the unsweetened cocoa and an effect on acne.

Primary Outcome

Number of lesions counted.

Interventions

  • DIETARY_SUPPLEMENT 100% cocoa powder
  • DIETARY_SUPPLEMENT gelatin (Gelita)

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2010-09
Est. Completion 2012-07
Phase NA
University of Miami

721 total trials

Why NCT01193764 stopped before completion

NCT01193764 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which 100% cocoa powder is the first listed.

NCT01193764 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01193764 about?

NCT01193764 is a clinical study titled "Study Assessing the Effect of Chocolate Consumption in Subjects With A History of Acne Vulgaris". The investigators conducted a recent pilot study and found a strong positive correlation between the consumption of 100% chocolate and acne exacerbation. However, this study had limitations including the lack of placebo and the small sample size. Although studies have been conducted assessing chocol...

What is the current status of trial NCT01193764?

This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2010-09. Estimated completion is 2012-07.

What interventions are being tested in trial NCT01193764?

The interventions under investigation include: 100% cocoa powder (DIETARY_SUPPLEMENT), gelatin (Gelita) (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01193764?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01193764's enrollment target sits among peer trials

14 1909th of 2000 higher than 90 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523092 · 14 participants · Phase 4

    Use of CXCL9 as a Biomarker of Acthar Efficacy

  • NCT04263285 · 14 participants · NA

    Treatment of Depression Post-SCI

  • NCT04743271 · 14 participants · NA

    Food and Circadian Timing

  • NCT05065671 · 14 participants · Phase 1

    Microbiome Derived Metabolism and Pharmacokinetics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01193764, the US trial registry maintained by the National Library of Medicine. NCT01193764 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.